Discover the power of discovery research, key trends shaping early-phase drug development, and two exclusive case studies from our Sacramento facility.

Discover a global CNS leader with 200+ studies completed to date and end-to-end drug development expertise—bridging translational gaps and accelerating your path from discovery to delivery.

An integrated nanomilling and spray-drying approach reduces particle size, enhances stability, and transforms nanosuspensions into scalable solid forms—boosting dissolution, bioavailability, and therapeutic success.

Leverage our expertise in nanomilling and spray drying to address low solubility and improve the bioavailability and efficacy of challenging drug compounds.

Discover how early clinical cognitive testing and dedicated driving simulation studies can help assess the cognitive functions for safety and efficacy in drug development.

In this article, we provide a detailed overview of the multiple facets you need to consider during the planning and conduct of your CNS-active drug development.

Industry experts explore the regulatory challenges of Schedule 1 drug development, including required studies, specialized assessments, and key formulation and manufacturing considerations.

Explore the unique challenges faced in the formulation development of ocular therapies and how they can be overcome to ensure safe, efficient, and targeted treatments for patients.

Dive into the world of ophthalmic drug development, where careful considerations in the preclinical phase must be taken to facilitate advancement into first-in-human clinical trials.

To maximize bioavailability while preserving vision and maintaining the structural integrity of the eye, formulation and delivery strategies must be meticulously designed.

Traditional toxicity studies don’t always fit today’s complex drug modalities. Watch as experts discuss how we’re adapting small molecule IND-enabling studies to meet modern therapeutic challenges.

Check out this essential webinar, where our experts provide an in-depth review of gene therapy approaches in nonhuman primates.

Learn how to identify which cognitive and pharmacodynamic tests are required for novel CNS-active drugs and best practices on conducting them during First-In-Human (FIH) trials.

Regulatory agencies prefer terminal sterilization over aseptic manufacturing, but is it suitable for your product? Industry manufacturing experts guide you in the selection and final delivery.

Globally recognized consultants discuss how they are addressing the most pressing drug development topics in the ocular field.

Gain valuable insights into the cutting-edge approaches shaping the future of gene and cell therapy delivery, ensuring more effective and efficient translation from discovery to clinical application.

Looking to avoid unnecessary delays and costly rework? Check out this webinar that shares important considerations for embarking on a new drug development program. Watch now!

<p>Learn how CROs and CDMOs work in tandem to successfully address operational and regulatory challenges for pharmaceutical and biotech companies, and how this can determine study success or failure.</p>

Learn about key topics in nanomilling, including practical applications and advantages, specialized equipment, milling media, stabilizers, as well as manufacturing and scale-up considerations.

Discover the advantages of LFHCs, including improved solubility and bioavailability, enhanced stability, and customizable release profiles, and how they can accelerate drug development timelines.

Learn how CROs and CDMOs work in tandem to address operational and regulatory challenges for pharmaceutical and biotech companies, and how this can determine study success or failure.

Learn more about the benefits of nanomilling, types of milling media and stabilizers, and scale up for clinical manufacturing.